Subodh Shrinivas Deshmukh
About Subodh Shrinivas Deshmukh
Data last updated:
Subodh Shrinivas Deshmukh is a Director at Aragen Biologics Private Limited (since 2025). The companies operate in Pharma. Aragen Biologics Private Limited reported revenue of ₹3.37 Cr (FY 2025). Earlier, Subodh Shrinivas Deshmukh was an Alternate Director at Novartis Healthcare Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aragen Biologics Private Limited U21001TS2023PTC174243 | Director | 28 Oct 2025 | 2023 | ₹3.37 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novartis Healthcare Private Limited U15202MH1997PTC111257 | Alternate Director | 20 Feb 2018 | 1997 | ₹6,088 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subodh Shrinivas Deshmukh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gunapati Reddy Venkat Keshav | 06593325 | Aragen Biologics Private Limited | Director |
| Latika Prakash Pradhan | 07118801 | Aragen Biologics Private Limited | Additional Director |
| Manmahesh Kantipudi | 05241166 | Aragen Biologics Private Limited | Director |
| Ramakrishna Kasturi | Aragen Biologics Private Limited | Company Secretary | |
| Robert Richard Ruffolo | 08404004 | Aragen Biologics Private Limited | Director |
| Sachin Anand Dharap | 00785700 | Aragen Biologics Private Limited | Cfo |
| Sachin Anand Dharap | Aragen Biologics Private Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subodh Shrinivas Deshmukh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subodh Shrinivas Deshmukh
Subodh Shrinivas Deshmukh currently holds 1 directorship: Aragen Biologics Private Limited (Director, since 28 Oct 2025, revenue ₹3.37 Cr (FY 2025)).
Subodh Shrinivas Deshmukh was first appointed on 20 Feb 2018 as Alternate Director at Novartis Healthcare Private Limited. The most recent appointment on record is 28 Oct 2025 at Aragen Biologics Private Limited.
Subodh Shrinivas Deshmukh held 1 earlier board appointment: Novartis Healthcare Private Limited (Alternate Director, 20 Feb 2018 to 14 Jan 2019).
The current boards of Subodh Shrinivas Deshmukh's companies include Gunapati Reddy Venkat Keshav (Aragen Biologics Private Limited), Latika Prakash Pradhan (Aragen Biologics Private Limited), Manmahesh Kantipudi (Aragen Biologics Private Limited), Ramakrishna Kasturi (Aragen Biologics Private Limited), Robert Richard Ruffolo (Aragen Biologics Private Limited), Sachin Anand Dharap (Aragen Biologics Private Limited), among others.